Prostate News Archive
05-Dec-2008
Prostate Cancer Stimulates Nerve Growth (HealthDay via Yahoo! News)
WEDNESDAY, Dec. 3 (HealthDay News) -- prostate cancer can promote the growth of new nerves that are associated with more aggressive tumors, U.S. researchers report. Degarelix prostate cancer drug makes testosterone levels fall dramatically and quickly (News-Medical-Net)
More than 95 per cent of men who took degarelix for prostate cancer saw their testosterone levels fall dramatically as early as three days after they started treatment, according to a paper in the December issue of BJU International. Bothell-based OncoGenex says prostate-cancer drug shows promise (Seattle Times)
Shares of OncoGenex Pharmaceuticals nearly doubled in value on Wednesday, as the company's experimental prostate-cancer treatment showed very promising interim results in a midstage clinical trial. Wartime diet of regular fasting slashes prostate cancer risk (Daily Mail)
Rationing food intake every few weeks could slash men's risk of prostate cancer, scientists believe. Men who halve the amount they normally eat for a week or two once a month could markedly lower their chances of a tumour at a young age.
Back to Prostate News Archive
